September 24, 2024 Press release - Non-regulatory Circio selected for oral presentation at ESGCT 2024 annual meeting
August 26, 2024 Press release - Non-regulatory Circio Holding ASA: Invitation to first half-year 2024 presentation on Thursday 29 August at 10:00am CEST
June 26, 2024 Press release - Non-regulatory Circio Holding ASA – Link to online subscription in the rights issue
June 25, 2024 Press release - Non-regulatory Circio´s leading position in circular RNA therapeutics highlighted by broad recent coverage in international life science industry media
June 17, 2024 Press release - Non-regulatory Circio announces strengthened in vivo data and enhanced circVec 2.2 design, presented by management in R&D webcast
May 13, 2024 Press release - Non-regulatory Circio presents pre-clinical proof-of-concept data for its circVec gene therapy platform at the ASGCT 2024 meeting
April 9, 2024 Press release - Non-regulatory Circio invites to a company update on Wednesday 17 April 2024
March 4, 2024 Press release - Non-regulatory The TG01 IND application by Circio’s partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities
February 27, 2024 Press release - Non-regulatory Circio to participate in the Annual European Life Sciences CEO Forum in Zürich
February 1, 2024 Press release - Non-regulatory The first patient has been dosed in Circio’s TG01 triple combination study
